Palliative radiotherapy for symptomatic hepatocellular carcinoma improves survival in HCC or liver metastases
Palliative radiotherapy for symptomatic hepatocellular carcinoma improves survival in HCC or liver metastases
Trifluridine/tipiracil plus bevacizumab improves OS in mCRC
Stereotactic body radiation therapy (SBRT) followed by sorafenib in HCC improves OS
NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer
HER-Vaxx is safe and provides clinical benefit over standard of care chemo for patients with HER2-overexpressing gastric cancer
Zolbetuximab + mFOLFOX6 as 1L treatment shows significantly prolonged PFS and OS in CLDN18.2+/ HER2 mG/GEJ adenocarcinoma
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer
OPERA: Nonoperative modality (NOM) treatments of rectal cancer do not compromise the chance of cure
NIVO + chemo and NIVO + IPI continue to demonstrate clinically meaningful survival benefit vs chemo for advanced ESCC